Challenges
Our Solutions
Our portfolio gives you access to relevant data insights from across the pharmaceutical markets.
Learn more
About Us
The medical cannabis market is one of the youngest segments in the German pharmaceutical sector. As a pioneer in this field of market research, we have been collecting and analyzing data since the German medical cannabis market opened in 2017. Our unique portfolio of market analyses, initial consulting for your market entry, and customized workshops for your product launch positions your brands and products for success right from the start.
We provide the foundation you need: top-tier data quality down to highly granular regional levels.
We have been experts in the medical cannabis market from day one and, with highly granular regional structures and intelligently linked data sources, deliver data quality at a very high level – giving you a clear edge in a highly dynamic market environment.
We believe the best way to plan your future offerings is with our Patient Insights. These are based on anonymized healthcare services data from more than 64 million patients, whose real-world care we have been capturing and analyzing since March 2020. This corresponds to around 77 percent of all statutory health insurance (SHI) patients in Germany. All results can be extrapolated to the overall SHI market. For this purpose, we use a data privacy–approved process for anonymized data collection via a trust center.
With our Patient Insights, you can analyze by parameters such as:
Tailored special analyses are also possible. We are happy to support and advise you on all questions related to patient-level insights.
Drawing on our collaboration with numerous leading industry partners and our deep understanding of the market, we developed the Green Line: Analytics and solutions designed to move you a quantum leap forward. Patient insights, product launch and lifecycle, sales management and targeting – we give your sales and marketing the powerful boost they need.
Analyze the entire German prescription drug market and present customer-specific market segments separately by statutory and private health insurance shares.
Work with regional sales volumes and revenue figures for prescriptions – based precisely on the SHI billing data from pharmacy billing centers.
Gain in-depth insights into monthly SHI billing data for prescriptions – broken down by substance, product, and trade-form prescriptions across 22 physician specialty groups.
Incorporate monthly purchasing data for all prescription medical cannabis products from community pharmacies – to support the best decisions in pharmaceutical marketing.
Analyze community pharmacy purchasing down to the local level – for a more targeted sales force, new market opportunities, and optimized regional marketing activities.
Compare your own products and those of your competitors down to the level of physician specialty groups – for precise physician target-group selection and optimized regional marketing.
The quarterly overview of overall developments in the medical cannabis market, based on our diverse data sources.